Clinical Trials Directory

Trials / Completed

CompletedNCT03233295

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Kwang Dong Pharmaceutical co., ltd. · Industry
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in adults with Vitamin D Deficiency

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3 B.O.N. Injectioncholecalciferol 200,000IU

Timeline

Start date
2014-10-23
Primary completion
2016-08-27
Completion
2016-08-27
First posted
2017-07-28
Last updated
2017-07-28

Source: ClinicalTrials.gov record NCT03233295. Inclusion in this directory is not an endorsement.